Certara
Anna Largajolli, PhD, is an Associate Director Modeler consultant at Certara’s Integrated Drug Development division.
She holds a M.Sc. in bioengineering from Padova University and from the same university a PhD in Pharmacometric modelling with a focus in the diabetes area. She has around ten years of experience in modelling thanks to the different international experience in academia (Visiting PhD student in Cape Town University and Postdoctoral research fellow in Uppsala University) and industry (GsK). Her solid technical background combined with a strong interest in clinical pharmacology permit her to adapt efficiently to the different research challenges.
Anna has been working in Certara for 5 years as an Associate Director Modeler consultant. She has been involved in different phases of clinical development as well as translational PKPD where she applied Pharmacometric modelling for drug development and contributed to regulatory filings.
Disclosure information not submitted.
Thursday, May 12, 2022
8:00 AM – 12:00 PM ET